Table I.
Ultrasound and hormonal results during two consecutive menstrual cycles in women receiving E2 or GnRH antagonist in the luteal phase.
|
GnRH antagonist group (B)/Day 3
|
E2 group(A)/Day 3
|
Parameter | ||||
|---|---|---|---|---|---|---|
| p-value | GnRH antagonist | Baseline | p value | E2 | Baseline | |
| 0.648** | 9.60±1.57 | 9.73±1.31 | 0.515** | 10.17±1.23 | 10.33±1.35 | No. of follicles (range) |
| 0.0001** | 4.13±1.11 | 8.73±1.96 | 0.0001** | 4.30±0.92 | 7.63±2.11 | Mean follicular size (mm) |
| 0.246*** | 1.11 | 1.96 | 0.869*** | 0.92 | 2.11 | SD follicular size (mm) |
| 0.206* | 9.67±2.03 | 9.35±1.83 | 0.407* | 9.5±1.44 | 9.33±1.65 | Mean ovarian volume (cm3) |
| 0.0001* | 21.36±13.18 | 30.73±11.06 | 0.0001* | 19.46±11.38 | 29.53±9.27 | Serum inhibin B (pg/mL) |
| 0.246* | 45.20±17.81 | 50.80±19.11 | 0.001* | 75.07±34.97 | 48.53±22.64 | Serum E2 (pg/mL) |
| 0.002* | 5.53±1.60 | 6.49±1.66 | 0.025* | 4.96±2.03 | 5.77±1.83 | Serum FSH (mIU/mL) |
P<0.05 =Significant level.
*
Paired samples t-test .
**
Wilcoxon signed ranks .
***
Levene's test for equality of variances.